Dr. Maju Mathews, MD

NPI: 1508801010
Total Payments
$2,245
2024 Payments
$782.29
Companies
24
Transactions
153
Medicare Patients
132
Medicare Billing
$37,029

Payment Breakdown by Category

Food & Beverage$2,234 (99.5%)
Education$11.13 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,234 150 99.5%
Education $11.13 3 0.5%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $809.30 62 $0 (2024)
Otsuka America Pharmaceutical, Inc. $249.85 16 $0 (2024)
Axsome Therapeutics, Inc. $145.69 9 $0 (2024)
Sunovion Pharmaceuticals Inc. $117.35 9 $0 (2022)
Lundbeck LLC $92.94 6 $0 (2024)
Vanda Pharmaceuticals Inc. $90.87 6 $0 (2024)
Corium, LLC $86.95 6 $0 (2024)
Bausch Health US, LLC $75.01 5 $0 (2024)
Alkermes, Inc. $72.37 5 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $63.48 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $782.29 47 Otsuka America Pharmaceutical, Inc. ($179.85)
2023 $646.11 41 ABBVIE INC. ($393.45)
2022 $533.30 39 ABBVIE INC. ($200.75)
2021 $231.34 20 AbbVie Inc. ($151.87)
2020 $14.48 1 Allergan, Inc. ($14.48)
2019 $12.11 1 Sunovion Pharmaceuticals Inc. ($12.11)
2018 $13.90 1 Otsuka America Pharmaceutical, Inc. ($13.90)
2017 $11.13 3 Sunovion Pharmaceuticals Inc. ($11.13)

All Payment Transactions

153 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/19/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $13.79 General
Category: Psychology/Psychiatric
12/13/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $18.00 General
Category: PSYCHIATRY
12/04/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.21 General
Category: NEUROSCIENCE
11/27/2024 LivaNova USA, Inc. VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) Food and Beverage In-kind items and services $23.58 General
Category: Neurology
11/15/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $17.33 General
Category: PSYCHIATRY
11/11/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $18.35 General
Category: PSYCHIATRY
11/07/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.30 General
Category: NEUROSCIENCE
11/06/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $21.33 General
Category: Neuropsychiatry
10/28/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $18.15 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
10/22/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $14.44 General
Category: PSYCHIATRY
10/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $20.66 General
Category: Neuropsychiatry
10/11/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $13.96 General
Category: Psychology/Psychiatric
10/10/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $13.32 General
10/07/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MYCITE (Drug) Food and Beverage In-kind items and services $18.63 General
Category: PSYCHIATRY
10/07/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $18.19 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
10/04/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $17.71 General
Category: Psychology/Psychiatric
09/25/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $16.48 General
Category: PSYCHIATRY
09/24/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.78 General
Category: NEUROSCIENCE
09/18/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $16.31 General
Category: SCHIZOPHRENIA
09/17/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA Food and Beverage In-kind items and services $13.09 General
Category: PSYCHIATRY
08/23/2024 Noven Therapeutics, LLC Xelstrym (Drug) Food and Beverage In-kind items and services $16.31 General
Category: ADHD
08/20/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MYCITE (Drug) Food and Beverage In-kind items and services $18.42 General
Category: PSYCHIATRY
08/16/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $16.58 General
Category: Psychology/Psychiatric
08/14/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA Food and Beverage In-kind items and services $15.77 General
Category: PSYCHIATRY
08/08/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $18.53 General
Category: Psychology/Psychiatric

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 44 147 $25,400 $8,915
2022 4 76 357 $64,025 $25,722
2021 1 12 29 $5,800 $2,392
Total Patients
132
Total Services
533
Medicare Billing
$37,029
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 22 67 $13,400 $5,200 38.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 22 80 $12,000 $3,714 31.0%
90834 Psychotherapy, 45 minutes Office 2022 19 175 $30,625 $12,686 41.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 26 107 $21,350 $8,021 37.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 20 61 $9,150 $3,280 35.9%
90791 Psychiatric diagnostic evaluation Office 2022 11 14 $2,900 $1,735 59.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 12 29 $5,800 $2,392 41.2%

About Dr. Maju Mathews, MD

Dr. Maju Mathews, MD is a Psychiatry healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508801010.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maju Mathews, MD has received a total of $2,245 in payments from pharmaceutical and medical device companies, with $782.29 received in 2024. These payments were reported across 153 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,234).

As a Medicare-enrolled provider, Mathews has provided services to 132 Medicare beneficiaries, totaling 533 services with total Medicare billing of $37,029. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Marlton, NJ
  • Active Since 06/18/2006
  • Last Updated 07/21/2022
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1508801010

Products in Payments

  • VRAYLAR (Drug) $823.78
  • REXULTI (Drug) $172.24
  • Auvelity (Drug) $145.69
  • LATUDA (Drug) $117.35
  • ABILIFY MYCITE (Drug) $100.20
  • CAPLYTA (Drug) $83.24
  • Azstarys (Drug) $75.10
  • APLENZIN (Drug) $75.01
  • HETLIOZ (Drug) $74.56
  • ARISTADA (Drug) $72.37
  • TRINTELLIX (Drug) $63.48
  • NEUROSTAR TMS THERAPY SYSTEM (Device) $62.65
  • INGREZZA (Drug) $55.49
  • JORNAY PM (Drug) $36.34
  • Xelstrym (Drug) $32.15
  • ABILIFY MAINTENA (Drug) $29.76
  • ABILIFY ASIMTUFII (Drug) $28.86
  • Austedo XR (Drug) $27.07
  • QUVIVIQ (Drug) $25.73
  • VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $23.58

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Marlton